Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis

Abstract Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous cancer with limited therapeutic options. Using publicly available datasets, we identified the WD repeat domain 54 (WDR54) gene as a potential therapeutic target in HNSCC. Gene expression profiling interactive analysis version...

Full description

Saved in:
Bibliographic Details
Main Authors: Eun-jeong Jeong, Eunjeong Kim, Yeon Soo Kim
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-83680-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559411576799232
author Eun-jeong Jeong
Eunjeong Kim
Yeon Soo Kim
author_facet Eun-jeong Jeong
Eunjeong Kim
Yeon Soo Kim
author_sort Eun-jeong Jeong
collection DOAJ
description Abstract Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous cancer with limited therapeutic options. Using publicly available datasets, we identified the WD repeat domain 54 (WDR54) gene as a potential therapeutic target in HNSCC. Gene expression profiling interactive analysis version 2 (GEPIA2) was used to identify genes differentially overexpressed in HNSCC. Our results showed that WDR54, a member of the WD40 repeat domain family, was overexpressed in HNSCC tumor samples. Analysis of three gene expression omnibus datasets showed that WDR54 was overexpressed in tumor samples. Using the UALCAN database, we showed that WDR54 expression in patients with HNSCC at different tumor stages gradually increased with disease progression. We confirmed the association between WDR54 and metastasis using TNMplot.com. WDR54 was overexpressed in metastatic samples compared to that in normal and tumor samples. Kaplan–Meier analysis showed that patients with high WDR54 levels had a poorer prognosis. Additionally, WDR54 expression was correlated with the epidermal growth factor receptor, which is frequently overexpressed in HNSCC. Our findings suggest that WDR54 is a promising biomarker and therapeutic target in HNSCC.
format Article
id doaj-art-122a4ef2008840a9b277562a33daa8b4
institution Kabale University
issn 2045-2322
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-122a4ef2008840a9b277562a33daa8b42025-01-05T12:29:30ZengNature PortfolioScientific Reports2045-23222024-12-0114111310.1038/s41598-024-83680-1Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysisEun-jeong Jeong0Eunjeong Kim1Yeon Soo Kim2Department of Otorhinolaryngology–Head and Neck Surgery, Konyang University College of MedicineInstitute of Basic Sciences, BK21 FOUR KNU Creative BioResearch Group, Department of Biology, College of Natural Sciences, KNU G-LAMP Research Center, KNU, Kyungpook National UniversityDepartment of Otorhinolaryngology–Head and Neck Surgery, Korea University College of MedicineAbstract Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous cancer with limited therapeutic options. Using publicly available datasets, we identified the WD repeat domain 54 (WDR54) gene as a potential therapeutic target in HNSCC. Gene expression profiling interactive analysis version 2 (GEPIA2) was used to identify genes differentially overexpressed in HNSCC. Our results showed that WDR54, a member of the WD40 repeat domain family, was overexpressed in HNSCC tumor samples. Analysis of three gene expression omnibus datasets showed that WDR54 was overexpressed in tumor samples. Using the UALCAN database, we showed that WDR54 expression in patients with HNSCC at different tumor stages gradually increased with disease progression. We confirmed the association between WDR54 and metastasis using TNMplot.com. WDR54 was overexpressed in metastatic samples compared to that in normal and tumor samples. Kaplan–Meier analysis showed that patients with high WDR54 levels had a poorer prognosis. Additionally, WDR54 expression was correlated with the epidermal growth factor receptor, which is frequently overexpressed in HNSCC. Our findings suggest that WDR54 is a promising biomarker and therapeutic target in HNSCC.https://doi.org/10.1038/s41598-024-83680-1Head and neck squamous cell carcinomaWD repeat domain 54Gene expression profiling interactive analysis web serverGene expression omnibus
spellingShingle Eun-jeong Jeong
Eunjeong Kim
Yeon Soo Kim
Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis
Scientific Reports
Head and neck squamous cell carcinoma
WD repeat domain 54
Gene expression profiling interactive analysis web server
Gene expression omnibus
title Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis
title_full Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis
title_fullStr Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis
title_full_unstemmed Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis
title_short Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis
title_sort identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis
topic Head and neck squamous cell carcinoma
WD repeat domain 54
Gene expression profiling interactive analysis web server
Gene expression omnibus
url https://doi.org/10.1038/s41598-024-83680-1
work_keys_str_mv AT eunjeongjeong identificationofnoveltherapeutictargetsforheadandnecksquamouscellcarcinomathroughbioinformaticsanalysis
AT eunjeongkim identificationofnoveltherapeutictargetsforheadandnecksquamouscellcarcinomathroughbioinformaticsanalysis
AT yeonsookim identificationofnoveltherapeutictargetsforheadandnecksquamouscellcarcinomathroughbioinformaticsanalysis